MedDataX Logo

Multidisciplinary Team in Management of Placenta Accreta

NCT ID: NCT03372538

Last Updated: 2017-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-31

Study Completion Date

2018-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

comparative study between the incidence of urological injury in case of placenta accreta in cases where urological surgical staff are participating in the operation from the start and in cases where the operation is carried by the gynecological staff only

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

cohort of 1000 patients of placenta accreta are followed regarding the incidence of urological injury in the cases with assistance from the urological staff members

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Placenta Accreta

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

placenta accreta

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

multidisciplinary team group

500 patients of placenta accreta managed by obstetricans and urologists

cesarean section or cesarean hysterectomy

Intervention Type PROCEDURE

upper segment cesarean section and or cesarean hysteroctomy

obstetricians only group

500 patients of placenta accreta managed by obstetricans only

cesarean section or cesarean hysterectomy

Intervention Type PROCEDURE

upper segment cesarean section and or cesarean hysteroctomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cesarean section or cesarean hysterectomy

upper segment cesarean section and or cesarean hysteroctomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant 38 weeks
* placenta accreta

Exclusion Criteria

* medical disorders complicating pregnancy
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

sarah mohamed hassan

lecturer of obstetrics and gynecology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr El Ainiy Hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

494608

Identifier Type: -

Identifier Source: org_study_id